Abobakr et al. (2023) observed positive CD44 expression in 91.6% of malignant cells in pediatric BCP-ALL and associated it with poor prognostic factors such as high peripheral blood blast counts, hepatomegaly, and splenomegaly [32]. The gene discussed is CD44; the disease is acute lymphoblastic leukemia.